II. Epidemiology
- Lead levels in children increased during the 20th century, peaking in the 1970s
- Even in the U.S. in 2017, lead levels >5 mcg are seen in more than 500,000 children
III. Causes: Most Common
- Lead-based paint and lead contaminated soil account for 70% of cases
- Contaminated drinking water and imported goods (e.g. candies, spices, pottery) account for 30% of cases
IV. Causes: General
- Home renovation or remodel
- Household dust
- Paint chips from lead-based paint
- Lead-based paint was banned in U.S. in 1978
- Older housing is likely to still contain residual lead
- Drinking water from lead pipes (or contaminated from lead solder, valves or fixtures)
- Restricted use of lead in pipes was restricted as of 1986 in U.S. (but still found in municipal pipes, older homes)
- Flint Water Crisis started in 2014 and resulted from lead contaminated water
- Steel or cast iron bathtubs coated in porcelain glaze
- Lead is exposed when porcelain breaks down (lead then leaches into bathwater)
- Industrial waste exposure (e.g. soil contaminated with lead)
- Residence near busy highway
- Regional airport with piston engine aircraft
- Tea Kettles and pottery
- Vinyl mini blinds
- Imported candy (e.g. Tamarind candy from Mexico stored in lead-contaminated ceramics)
- Imported eye cosmetics (e.g. Kohl or Surma from India, or other eye cosmetics from Pakistan)
- Imported Jewelry or Toys
- Parents with occupational exposure (i.e. Take-home exposures)
- Lead production or smelting
- Battery manufacturing or battery reclamation
- Brass, copper or lead foundry
- Radiator repair
- Scrap handling
- Ship and bridge demolition
- Old painted metal welding
- Thermal paint stripping of old buildings
- Old paint sanding
- Lead soldering
- Ceramic glaze mixing
- Cable stripping
- Firing range staff
- Machining or grinding lead alloys
-
Pica secondary to Anemia
- Eating lead paint or soil
- Herbal remedies containing lead
V. Risk Factors
- Children younger than 5 years (esp. 6-12 months, peaking at ages 18-36 months)
-
Iron Deficiency Anemia (4-5x Relative Risk)
- Lead and iron are both absorbed from Gastrointestinal Tract via the same transporter
- In Iron Deficiency, the transporter is upregulated and therefore absorbs more lead
- Communities with lead-containing water service lines (or poor anticorrosion control, e.g. Flint, MI)
- Communities with known elevated blood lead levels
- Formula fed infants living in communities with lead contaminated water supplies
- Close proximity to current or former industrial plants with lead emissions (batteries, smelting plants)
- High poverty regions with older, poorly maintained homes
- Immigrants or Refugees
- Parent with occupation or hobby that exposes them to lead (see causes below)
VI. Symptoms
- Nonspecific even at high levels (45 mcg/dl)
- Very high levels
VII. Signs
- Lead line in gums
- Papilledema
- Ocular palsy
- Wrist Drop
- Foot Drop
- Slurred speech
- Reflex changes
- Bradycardia
- Hypotension
- Mental status changes
VIII. Labs: Screening
- Blood Lead Level
- See below for protocol
- May screen lead level with capillary blood test
- Confirm all abnormal capillary blood tests with venous blood draw lead level
- Indications
- Previously universal screening was in place before 1997 in United States
- Now screen child considered high risk or all children for whom risk is unknown or uncertain
- All Medicaid enrolled or eligible children
- Obtain lead level at 12 months and 24 months
- Catch-up at age 36-72 months if not already done
- All recent Immigrant Children (or Refugees, adoptees)
- Initial lead level on arrival in U.S.
- Repeat screening in 3-6 months later (for ages 6 months to 6 years old)
- High risk children
- Identified by CDC, state or local screening recommendations (i.e. high risk zip codes)
- Child lives in, visits, or attends child care in a house built before 1950
- Child lives in, visits, or attends child care in a house built before 1978 with renovation in last 6 months
- Child has sibling or playmate that has Lead Poisoning
- Previously universal screening was in place before 1997 in United States
IX. Labs: Advanced (indicated for lead level >20 mcg/dl or 0.97 umol/L)
-
Peripheral Smear
- Stippled erythrocytes
- Complete Blood Count (CBC)
- Iron Deficiency Anemia labs (TIBC, Ferritin)
- Reticulocyte Count
- Urinalysis
- Comprehensive metabolic panel
X. Labs: Other findings suggestive of Lead Toxicity
- Urine lead level elevated
- Urine microscopy of sediment or renal biopsy
- Acid-fast inclusion bodies in tubular nuclei
- Pathognomonic for Lead Poisoning
- Free Erythrocyte Protoporphyrin (FEP) > 0.6 umol/L
XI. Imaging
- Abdominal XRay
- Indicated for moderate, high or very high lead level of 20 mcg/dl or greater
- Identifies lead remaining in the intestinal tract (radiodense)
- Long bone XRay
- Epiphyseal lead line
XII. Protocol
- Precautions
- Education and evaluation should be done at all abnormal lead levels
- Counseling regarding common lead exposures and prevention
- Nutrition counseling to increase Calcium and iron intake
- Evaluate Developmental Milestones and environmental exposures
- Formal environmental evaluation
- There is no known safe level of lead, and lead plays no beneficial role in human physiology
- Even blood lead levels 5 mcg/dl have been associated with permanent neurocognitive and behavioral deficits
- Education and evaluation should be done at all abnormal lead levels
- Lead level 5-9 mcg/dl (0.24 to 0.43 umol/L): Low Lead Toxicity level
- Obtain venous lead level confirmation at one to three months
- Lead level 10-14 mcg/dl (0.48 to 0.68 umol/L): Low Lead Toxicity level
- Obtain venous lead level confirmation within one month
- Lead level at 0 months
- Lead level at 3 months
- Lead level at 6-9 months
- Lead level 15-19 mcg/dl (0.72 to 0.92 umol/L): Low Lead Toxicity level
- Obtain venous lead level confirmation within one month
- Lead level at 0 months
- Lead level at 1-3 months
- If lead level still >15 mcg/dl proceed to follow lead level of 20-44 mcg/dl
- If lead level <15 mcg/dl, continue with education and observation
- Lead level at 3-6 months
- Lead level 20-44 mcg/dl (0.97 to 2.13 umol/L): Moderate Lead Toxicity level
- Obtain venous lead level confirmation within one month
- Lead level at 0 months
- Environmental investigation and lead hazard reduction
- Complete history, exam, XRay as above
- Obtain Hemoglobin, Hematocrit and lead level
- Consider bowel Decontamination if ingestion suspected (consider abdominal XRay)
- Enemas used to clear retained lead products
- Lead level at 2-4 weeks
- Lead level at 1 month
- Lead level 45-69 mcg/dl (2.17 to 3.33 umol/L): High Lead Toxicity level
- Obtain venous lead level confirmation within 48 hours (24 hours if >60)
- Complete history, exam, Neurologic Exam, XRay as above
- Obtain Hemoglobin, Hematocrit and lead level
- Lead level at 0 months
- Includes measure done for lead level of 20-44 mcg/dl
- Lead level pre-chelation
- Outpatient Chelation therapy
- Lead level post-chelation
- Obtain venous lead level confirmation within 48 hours (24 hours if >60)
- Lead level >70 mcg/dl (>3.38 umol/L): Very high Lead Toxicity level
- Obtain venous lead level confirmation emergently
- Lead level at 0 months
- Includes measure done for lead level of 20-44 mcg/dl
- Immediate hospitalization for chelation therapy
- Lead level pre-chelation
- Inpatient chelation therapy
- Lead level post-chelation
XIII. Management: Chronic lead chelation
- Precautions
- Consult toxicologist (typically poison control in U.S.) before using chelation
- Obtain labs and diagnostics as above before chelation
- Dosing regimens should be checked with toxicology
- First-Line
- Succimer or Chemet (Meso-2,3-dimercaptosuccinic acid or DMSA)
- Initial: 10 mg/kg (or 350 mg/m2) PO every 8 hours for 5 days
- Next: 10 mg/kg (or 350 mg/m2) PO every 12 hours for 14 days
- Succimer or Chemet (Meso-2,3-dimercaptosuccinic acid or DMSA)
- Other Parenteral agents that have been used for lead chelation
- Other oral agents that have been used for lead chelation
- Penicillamine (Cuprimine)
- Dose: 20-40 mg/kg/day for 3 to 6 months
- Maximum: 1 grams per day
- Penicillamine (Cuprimine)
- Efficacy
- Chelation not affective if lead <45 mcg/dl
- Dietrich (2004) Pediatrics 114:19-26 [PubMed]
XIV. Management: Acute Lead Chelation
- Indications
- Acute Encephalopathy (e.g. Seizures, Altered Mental Status) AND
- Lead Toxicity confirmed with whole blood lead level
- Chelation agents
- British anti-Lewisite (BAL)
- Administered intramuscular (IM)
- Contraindicated in peanut allergy and G6PD Deficiency
- Calcium Disodium EDTA
- Administered after BAL
- Poor CNS penetration
- British anti-Lewisite (BAL)
- Protocol
- References
- Swadron and Nordt in Herbert (2016) EM:Rap 16(6): 13-4
XV. Complications: Untreated Lead Poisoning
- Aggressive and delinquent behavior
- Motor development deficits
- Language and cognitive deficits
- References
XVI. Prevention
- Precautions regarding drinking water from lead pipes
- Allow tap to flow for 30 seconds, then collect water
- Alternatively shower, bath, and flush toilets before using tap water for cooking
- Do not use hot water from tap for drinking (use only cold water or bottled water)
- Consider formal testing of house tap water for lead
- Allow tap to flow for 30 seconds, then collect water
- Basic house measures
- Wash childrens hands and toys frequently
- Wet mop floors and window sills every 2 weeks
- Remove shoes before entering house
- Avoid folk remedies, imported medicines, candies, pottery (esp. from developing countries)
- Avoid living near highways or industrial plants
- Eliminate lead exposures (soil, dust, paint, water)
- CDC and local data can be used to identify areas for environmental testing (e.g. house paint)
- Replace all lead paint with non-lead paints using lead-safe practices
- Carefully limit child's exposure during remodeling
- Carefully dispose of removed lead paint
XVII. Resources
- Lead Poisoning in Children (CDC)
- Drinking Water Contamination (EPA)
XVIII. References
- Tagliaferro (2023) Crit Dec Emerg Med 37(1): 21-9
- (2005) Pediatrics 116(4): 1036-46 [PubMed]
- Chao (1993) Am Fam Physician 47:113-20 [PubMed]
- Dietrich (2004) Pediatrics 114(1): 19-26 [PubMed]
- Mayans (2019) Am Fam Physician 100(1):24-30 [PubMed]
- Rogan (2001) N Engl J Med 344(19): 1421-6 [PubMed]
- Warniment (2010) Am Fam Physician 81(6): 751-60 [PubMed]